oncology

New Payment Model Improves Cancer Care at Oncology GroupCEO of a Pennsylvania-based oncology group shares how participating in a new value-based model is changing the care approach.
Top 10 AMCP Sessions Health Execs Should AttendAttending the AMCP Managed Care and Specialty Pharmacy Annual Meeting in Boston April 23 to April 26? Here are our top session recommendations.
Burnout Hits Oncologists Hard, but Healthcare Systems Can Help
Burnout Hits Oncologists Hard, but Healthcare Systems Can HelpHealthcare systems stand to lose $6 million if burned out physicians choose to resign or work elsewhere. Here are some ways to curb burnout and its associated costs.
FDA approves revolutionary blood cancer treatmentFDA’s approval of a new combination treatment for patients with classical Hodgkin lymphoma (cHL) is the first new advanced treatment for the disease in 40 years
Improve Care Coordination in Cancer Care: 2 Key Focus AreasWhen caring for cancer patients, improving care coordination in these two areas is key—and it can help reduce healthcare costs.
Nine Healthcare Apps Healthcare Executives Wish They HadIf there was one app that you could create, what would it be? We asked top healthcare executives. Here’s what they said.
Top 3 new cancer drugs
Top 3 new cancer drugsThe first radioactive drug to treat a certain type of cancer is among the top 3 new drug approvals for cancer. Here are the other top cancer drug approvals so far in 2018.
Seven diseases benefiting from genetic tests
Seven diseases benefiting from genetic testsGenetic testing is playing a growing role in diagnosing and treating diseases, particularly when it comes to certain cancers and rheumatic conditions.
What Roche’s Purchase of Flatiron Health Means for Health ExecsSwitzerland-based pharma company Roche’s $1.9 billion purchase of tech company Flatiron Health signifies Big Pharma’s need for data.
Two Ways to Take Charge of CAR T-Cell Therapy CostsSuccessful CAR T-cell therapy reimbursement begins with careful payer-provider collaboration and taking these two approaches.